Truvestments Capital LLC Boosts Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Truvestments Capital LLC raised its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 30.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,082 shares of the company’s stock after acquiring an additional 4,421 shares during the quarter. Truvestments Capital LLC owned approximately 0.21% of Semler Scientific worth $1,030,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Global Retirement Partners LLC increased its holdings in Semler Scientific by 62.5% during the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock valued at $70,000 after acquiring an additional 500 shares in the last quarter. Sanctuary Advisors LLC grew its holdings in shares of Semler Scientific by 13.2% during the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company’s stock worth $261,000 after buying an additional 584 shares in the last quarter. Jones Financial Companies Lllp purchased a new stake in shares of Semler Scientific during the fourth quarter worth about $34,000. Larson Financial Group LLC purchased a new stake in shares of Semler Scientific during the fourth quarter worth about $38,000. Finally, State Street Corp grew its holdings in shares of Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after buying an additional 725 shares in the last quarter. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Semler Scientific Price Performance

Shares of NASDAQ SMLR opened at $32.80 on Wednesday. The company has a 50-day simple moving average of $50.52 and a 200-day simple moving average of $43.80. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The company has a market cap of $314.78 million, a PE ratio of 6.68 and a beta of 1.33.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The business had revenue of $12.41 million for the quarter.

Analysts Set New Price Targets

Separately, Lake Street Capital lifted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.